止血
纤溶
凝结
医学
凝血病
肝病
血栓形成
血小板
免疫学
内科学
作者
Emmanuelle de Raucourt,Dominique Valla,Pierre‐Emmanuel Rautou
出处
期刊:Elsevier eBooks
[Elsevier]
日期:2020-01-01
卷期号:: 418-428
标识
DOI:10.1016/b978-0-12-801238-3.65706-9
摘要
Hemostasis is a complex and well controlled process that requires the interplay of multiple players to generate localized clot formation to prevent or stop bleeding. The liver plays a critical role in hemostasis as it synthetizes most of the proteins involved in coagulation and fibrinolysis and produces thrombopoietin that regulates platelet production. Furthermore, the liver is involved in clearance of many hemostatic and fibrinolytic components. Liver diseases induce major modifications in hemostasis and are associated with endothelial activation. As a result, a complex coagulopathy may develop in patients with liver diseases where both bleeding and thrombosis can ensue. This article presents coagulation changes occurring in patients with liver diseases, thrombosis and bleeding risk as well as insight into the management of anticoagulation and of invasive procedures in these patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI